Latest

Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’
Canaccord Genuity went on social media to gauge the reaction. Even the MAHA crowd was mixed on this one.
